DCX and prostate cancer: reported that DCX‐positive neural progenitor cells from the central nervous system (CNS) can traverse the blood–brain barrier and migrate to prostate cancer tissues through the bloodstream and reside in the tumor tissues, where they generate new adrenergic neurons that may contribute to prostate cancer progression [61].